MV Capital Management
EW icon

MV Capital Management’s Edwards Lifesciences EW Stock Holding History

MV Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.4K Sell
317
-18
-5% -$1.6K ﹤0.01% 412
2026
Q2 		$30.3K Buy
335
+20
+6% +$1.68K ﹤0.01% 406
2026
Q1 		$25.2K Buy
315
+7
+2% +$577 ﹤0.01% 412
2025
Q4 		$26.3K Buy
308
+2
+0.7% +$164 ﹤0.01% 404
2025
Q3 		$23.8K Buy
306
+1
+0.3% +$78 ﹤0.01% 418
2025
Q2 		$23.9K Buy
305
+51
+20% +$3.8K ﹤0.01% 417
2025
Q1 		$18.4K Sell
254
-20
-7% -$1.43K ﹤0.01% 445
2024
Q4 		$20.3K Buy
274
+4
+1% +$280 ﹤0.01% 426
2024
Q3 		$17.8K Sell
270
-98
-27% -$7.12K ﹤0.01% 443
2024
Q2 		$34K Buy
368
+33
+10% +$2.92K ﹤0.01% 337
2024
Q1 		$32K Sell
335
-21
-6% -$1.76K ﹤0.01% 354
2023
Q4 		$27.1K Buy
356
+53
+17% +$3.69K ﹤0.01% 372
2023
Q3 		$21K Sell
303
-321
-51% -$25.8K ﹤0.01% 384
2023
Q2 		$58.9K Buy
624
+26
+4% +$2.26K 0.01% 275
2023
Q1 		$49.5K Buy
598
+270
+82% +$21.2K 0.01% 284
2022
Q4 		$24.5K Sell
328
-1
-0.3% -$77 ﹤0.01% 310
2022
Q3 		$27K Buy
329
+140
+74% +$13.5K ﹤0.01% 290
2022
Q2 		$18K Sell
189
-39
-17% -$4.04K ﹤0.01% 334
2022
Q1 		$27K Buy
228
+38
+20% +$4.26K ﹤0.01% 291
2021
Q4 		$25K Buy
190
+44
+30% +$5.13K ﹤0.01% 286
2021
Q3 		$17K Buy
146
+54
+59% +$6.16K ﹤0.01% 337
2021
Q2 		$10K Buy
92
+77
+513% +$7.26K ﹤0.01% 363
2021
Q1 		$1K Buy
+15
New +$1.27K ﹤0.01% 359
2015
Q3 		– Sell
-492
Closed -$12K – 311
2015
Q2 		$12K Hold
492
– – ﹤0.01% 290
2015
Q1 		$12K Hold
492
– – 0.01% 273
2014
Q4 		$10K Buy
+492
New +$9.9K ﹤0.01% 289

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

MV Capital Management's EW Position: Q3 2026 in Review

MV Capital Management reduced its Edwards Lifesciences (EW) stake by 5.4% in Q3 2026, selling an estimated $1.6K and leaving 317 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

MV Capital Management first reported a position in EW in Q4 2014 and has held it in 26 quarters since. The position peaked at $58.9K in Q2 2023. 851 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • MV Capital Management held 317 shares of Edwards Lifesciences worth $27.4K as of Q3 2026.
  • MV Capital Management sold 18 Edwards Lifesciences shares in Q3 2026, an estimated $1.6K.
  • Edwards Lifesciences made up ﹤0.01% of MV Capital Management's portfolio in Q3 2026, its #412 holding.
  • MV Capital Management first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 26 quarters since.
  • MV Capital Management's Edwards Lifesciences position peaked at $58.9K in Q2 2023.
  • 851 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.